These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 22214424)

  • 21. Exploring the pharmacotherapeutic options for treating type 2 diabetes.
    Kruger DF
    Diabetes Educ; 2008; 34 Suppl 3():60S-65S. PubMed ID: 18525066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Achieving antihyperglycemic treatment goals with incretin-related therapies.
    Blonde L
    Am J Manag Care; 2012 Nov; 18(10 Suppl):S219-27. PubMed ID: 23327432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diabetes management. Analysis of the American Diabetes Association's clinical practice recommendations.
    Strano-Paul L; Phanumas D
    Geriatrics; 2000 Apr; 55(4):57-62; quiz 65. PubMed ID: 10771703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Incretins in the treatment of diabetes].
    Bulum T; Smircić-Duvnjak L; Car N; Metelko Z
    Lijec Vjesn; 2008; 130(7-8):195-200. PubMed ID: 18979908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incretin therapy for type 2 diabetes mellitus.
    Klonoff DC
    Adv Ther; 2010 Dec; 27(12):881-94. PubMed ID: 20978879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Incretins have changed and continue to change treatment strategy for type 2 diabetes].
    Kvapil M
    Vnitr Lek; 2011 Nov; 57(11):916-8. PubMed ID: 22165696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The intersection of safety and adherence: new incretin-based therapies in patients with type 2 diabetes mellitus.
    Zarowitz BJ; Conner C
    Pharmacotherapy; 2009 Dec; 29(12 Pt 2):55S-67S. PubMed ID: 19947817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treating diabetes with incretin hormones - clinical experience.
    Handelsman Y
    Pediatr Endocrinol Rev; 2008 Jun; 5(4):897-903. PubMed ID: 18552752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overview of the guidelines and evidence for the pharmacologic management of type 2 diabetes mellitus.
    Liday C
    Pharmacotherapy; 2011 Dec; 31(12 Suppl):37S-43S. PubMed ID: 22122221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beyond glycemic control: the effects of incretin hormones in type 2 diabetes.
    Martin CL
    Diabetes Educ; 2008; 34 Suppl 3():66S-72S. PubMed ID: 18525067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incretin-based therapies in type 2 diabetes: a review of clinical results.
    Bosi E; Lucotti P; Setola E; Monti L; Piatti PM
    Diabetes Res Clin Pract; 2008 Dec; 82 Suppl 2():S102-7. PubMed ID: 19022515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Type 2 diabetes mellitus: an evidence-based update.
    Zitkus BS
    Nurse Pract; 2012 Jul; 37(7):28-37. PubMed ID: 22739463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Incretin therapy and diabetic retinopathy].
    Kvapil M
    Vnitr Lek; 2013 Mar; 59(3):204-7. PubMed ID: 23713189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incretin hormones and their therapeutic potential in patients with type 2 diabetes. Preface.
    Nauck MA
    Best Pract Res Clin Endocrinol Metab; 2009 Aug; 23(4):vii. PubMed ID: 19748058
    [No Abstract]   [Full Text] [Related]  

  • 35. How do we continue treatment in patients with type 2 diabetes when therapeutic goals are not reached with oral antidiabetes agents and lifestyle? Incretin versus insulin treatment.
    Gallwitz B; Bretzel RG
    Diabetes Care; 2013 Aug; 36 Suppl 2(Suppl 2):S180-9. PubMed ID: 23882044
    [No Abstract]   [Full Text] [Related]  

  • 36. The benefits of yoga for adults with type 2 diabetes: a review of the evidence and call for a collaborative, integrated research initiative.
    de G R Hansen E; Innes KE
    Int J Yoga Therap; 2013; (23):71-83. PubMed ID: 24165527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emerging role of insulin with incretin therapies for management of type 2 diabetes.
    Ahluwalia R; Vora J
    Diabetes Ther; 2011 Sep; 2(3):146-61. PubMed ID: 22127824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The 39th scientific meeting: perspectives of internal medicine; the cutting edge of treatment of medical disorders encountered in clinical practice; 6. Incretin for treatment of type 2 diabetes].
    Yamada Y
    Nihon Naika Gakkai Zasshi; 2012 Mar; 101(3):631-5. PubMed ID: 22620026
    [No Abstract]   [Full Text] [Related]  

  • 39. Is combined exercise and incretin-based therapy the way forward for weight-loss maintenance?
    Abildgaard J
    Nat Rev Endocrinol; 2023 Oct; 19(10):558. PubMed ID: 37430036
    [No Abstract]   [Full Text] [Related]  

  • 40. Year in diabetes 2012: The diabetes tsunami.
    Sherwin R; Jastreboff AM
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4293-301. PubMed ID: 23185035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.